THYROID

THYROID was reported 2845 times

THYROID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EOSINOPHILIC GASTRITIS 2 0.0444
1 PLEURAL FIBROSIS 14 0.0137
2 APPENDIX DISORDER 14 0.0099
3 BURNING FEET SYNDROME 2 0.0080
4 CHRONIC DISEASE 2 0.0078
5 FALLOPIAN TUBE DISORDER 2 0.0068
6 APPLICATION SITE PUSTULES 2 0.0055
7 NECK INJURY 16 0.0054
8 CORNEAL DYSTROPHY 2 0.0048
9 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 10 0.0043
10 GINGIVAL ULCERATION 3 0.0040
11 BUTTERFLY RASH 4 0.0039
12 ALLERGIC SINUSITIS 3 0.0035
13 DOSE CALCULATION ERROR 2 0.0034
14 ADRENAL DISORDER 6 0.0031
15 HYPOVITAMINOSIS 4 0.0030
16 CEREBRAL CYST 2 0.0029
17 ANGULAR CHEILITIS 2 0.0029
18 CATAPLEXY 4 0.0028
19 CERVICAL RADICULOPATHY 2 0.0028
20 BUNION 2 0.0028
21 DENTAL RESTORATION FAILURE 2 0.0028
22 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 3 0.0027
23 BREAST CALCIFICATIONS 2 0.0025
24 COVID-19 IMMUNISATION 2 0.0024
25 FRACTURE NONUNION 3 0.0022
26 EXOSTOSIS 20 0.0022
27 INFUSION SITE RASH 3 0.0022
28 CERUMEN IMPACTION 2 0.0022
29 IMPATIENCE 4 0.0021
30 LYME DISEASE 7 0.0021
31 PRE-EXISTING CONDITION IMPROVED 13 0.0021
32 JUDGEMENT IMPAIRED 3 0.0021
33 INTRAMEDULLARY ROD INSERTION 4 0.0020
34 SPINAL COLUMN STENOSIS 9 0.0019
35 BONE NEOPLASM 2 0.0019
36 INFUSION SITE BRUISING 4 0.0019
37 ESSENTIAL TREMOR 2 0.0018
38 THYROID FUNCTION TEST ABNORMAL 7 0.0017
39 INSTILLATION SITE PAIN 4 0.0016
40 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
41 INFUSION SITE PRURITUS 5 0.0016
42 LIP DISORDER 3 0.0016
43 RHINITIS ALLERGIC 7 0.0016
44 GINGIVAL RECESSION 3 0.0016
45 C-REACTIVE PROTEIN ABNORMAL 10 0.0016
46 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
47 ANAEMIA POSTOPERATIVE 2 0.0015
48 RADICULOPATHY 4 0.0015
49 ACROCHORDON 2 0.0015
50 THYROID DISORDER 23 0.0015
51 CYSTITIS NONINFECTIVE 2 0.0015
52 BLOOD SODIUM INCREASED 4 0.0015
53 ANAL PRURITUS 3 0.0014
54 CHRONIC FATIGUE SYNDROME 2 0.0014
55 HANGOVER 5 0.0014
56 REACTION TO DRUG EXCIPIENTS 3 0.0014
57 FAT TISSUE INCREASED 2 0.0014
58 BILIARY DILATATION 2 0.0014
59 PRODUCT LOT NUMBER ISSUE 3 0.0014
60 TEMPERATURE REGULATION DISORDER 3 0.0013
61 LARGE INTESTINAL HAEMORRHAGE 3 0.0013
62 AUTOIMMUNE THYROIDITIS 5 0.0013
63 GINGIVAL DISORDER 5 0.0013
64 ENTHESOPATHY 2 0.0013
65 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
66 BRONCHITIS CHRONIC 3 0.0012
67 NEAR DEATH EXPERIENCE 4 0.0012
68 HEREDITARY ANGIOEDEMA 13 0.0012
69 ARTHROPOD STING 2 0.0012
70 ABDOMINAL INFECTION 3 0.0012
71 AORTIC ARTERIOSCLEROSIS 3 0.0012
72 HORDEOLUM 5 0.0012
73 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
74 YAWNING 3 0.0011
75 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
76 DRUG MONITORING PROCEDURE NOT PERFORMED 2 0.0011
77 EAR CONGESTION 3 0.0011
78 CONDUCTION DISORDER 2 0.0011
79 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
80 TOOTH ABSCESS 11 0.0011
81 AURA 2 0.0011
82 BLOOD IRON INCREASED 2 0.0011
83 POOR VENOUS ACCESS 11 0.0011
84 CARDIAC MURMUR 9 0.0010
85 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
86 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
87 JOINT EFFUSION 7 0.0010
88 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
89 BLADDER DISORDER 10 0.0010
90 CARDIAC DISCOMFORT 2 0.0010
91 CRANIOCEREBRAL INJURY 3 0.0010
92 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
93 CHEST INJURY 2 0.0010
94 DRUG EFFECT INCREASED 3 0.0009
95 CUSHINGOID 3 0.0009
96 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
97 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
98 VULVOVAGINAL DRYNESS 3 0.0009
99 BOWEL MOVEMENT IRREGULARITY 7 0.0009
100 PEPTIC ULCER 3 0.0009
101 HEART RATE ABNORMAL 5 0.0009
102 APPLICATION SITE URTICARIA 2 0.0009
103 VASCULAR DEVICE INFECTION 4 0.0009
104 DISLOCATION OF VERTEBRA 2 0.0009
105 EAR DISORDER 4 0.0009
106 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
107 EXERCISE TOLERANCE DECREASED 5 0.0009
108 SYNOVIAL CYST 4 0.0009
109 ROSACEA 4 0.0009
110 VAGINAL INFECTION 4 0.0008
111 CONTRAST MEDIA REACTION 2 0.0008
112 ENERGY INCREASED 5 0.0008
113 CATARACT OPERATION 5 0.0008
114 FRUSTRATION 3 0.0008
115 SYNOVITIS 15 0.0008
116 PANIC REACTION 6 0.0008
117 HORMONE LEVEL ABNORMAL 4 0.0008
118 THROMBOCYTOSIS 3 0.0008
119 INCORRECT DOSAGE ADMINISTERED 4 0.0008
120 LARYNGEAL OEDEMA 5 0.0008
121 CARTILAGE INJURY 2 0.0008
122 NERVE INJURY 9 0.0008
123 TENDON INJURY 3 0.0008
124 INFUSION SITE EXTRAVASATION 5 0.0008
125 INFUSION SITE SWELLING 5 0.0008
126 FRACTURE 15 0.0008
127 PRODUCT SOLUBILITY ABNORMAL 4 0.0008
128 DRUG TOLERANCE 4 0.0008
129 FACE INJURY 3 0.0008
130 DRY THROAT 8 0.0008
131 SLEEP APNOEA SYNDROME 15 0.0008
132 THYROID MASS 3 0.0008
133 INITIAL INSOMNIA 8 0.0008
134 TRISMUS 4 0.0008
135 MUSCLE RUPTURE 3 0.0008
136 MALABSORPTION 4 0.0008
137 PROSTATOMEGALY 3 0.0008
138 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
139 OESOPHAGEAL PAIN 3 0.0008
140 SERUM FERRITIN INCREASED 4 0.0008
141 NASAL DISCOMFORT 6 0.0008
142 GINGIVAL PAIN 6 0.0008
143 FOREIGN BODY 3 0.0007
144 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
145 VITAMIN B12 DEFICIENCY 3 0.0007
146 HEAD DISCOMFORT 13 0.0007
147 HYPERURICAEMIA 3 0.0007
148 HYPERKERATOSIS 4 0.0007
149 DENTAL CARIES 8 0.0007
150 GASTROENTERITIS VIRAL 13 0.0007
151 ANGIOPATHY 4 0.0007
152 DEFAECATION URGENCY 5 0.0007
153 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
154 INFUSION SITE ERYTHEMA 6 0.0007
155 HEART RATE IRREGULAR 16 0.0007
156 TONGUE DISCOMFORT 3 0.0007
157 AORTIC VALVE INCOMPETENCE 3 0.0007
158 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
159 IMPAIRED DRIVING ABILITY 8 0.0007
160 DIVERTICULUM 5 0.0007
161 BONE PAIN 41 0.0007
162 FIBULA FRACTURE 2 0.0007
163 HEPATIC LESION 3 0.0007
164 MADAROSIS 8 0.0007
165 BLOOD PARATHYROID HORMONE INCREASED 2 0.0007
166 TONGUE DISCOLOURATION 3 0.0007
167 DYSPHEMIA 3 0.0007
168 OSTEOARTHRITIS 29 0.0007
169 INTENTIONAL DEVICE MISUSE 3 0.0007
170 HEARING IMPAIRED 4 0.0007
171 CEREBROVASCULAR DISORDER 2 0.0007
172 CENTRAL VENOUS CATHETERISATION 2 0.0007
173 PLATELET COUNT ABNORMAL 4 0.0007
174 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
175 BODY HEIGHT DECREASED 7 0.0007
176 PNEUMONIA BACTERIAL 6 0.0007
177 CHEST X-RAY ABNORMAL 2 0.0007
178 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
179 CHRONIC MYELOID LEUKAEMIA 3 0.0006
180 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
181 SCOLIOSIS 4 0.0006
182 BLOOD CHOLESTEROL INCREASED 30 0.0006
183 PERFORMANCE STATUS DECREASED 3 0.0006
184 CARPAL TUNNEL SYNDROME 9 0.0006
185 BLOOD BLISTER 2 0.0006
186 SEASONAL ALLERGY 9 0.0006
187 SPINAL DISORDER 6 0.0006
188 BREAST CANCER RECURRENT 2 0.0006
189 SARCOIDOSIS 3 0.0006
190 ENDOMETRIOSIS 3 0.0006
191 HYPERCHOLESTEROLAEMIA 6 0.0006
192 FRUSTRATION TOLERANCE DECREASED 5 0.0006
193 MUSCLE DISORDER 5 0.0006
194 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
195 TENDON DISORDER 4 0.0006
196 COELIAC DISEASE 6 0.0006
197 BREAST ENLARGEMENT 2 0.0006
198 RETCHING 13 0.0006
199 SOMNAMBULISM 4 0.0006
200 WALKING AID USER 4 0.0006
201 INFLAMMATORY MARKER INCREASED 3 0.0006
202 APPETITE DISORDER 4 0.0006
203 HEMIPLEGIA 5 0.0006
204 HYPOAESTHESIA ORAL 9 0.0006
205 HYPOTHYROIDISM 19 0.0006
206 OSTEOPENIA 9 0.0006
207 PHOTOPHOBIA 11 0.0006
208 TOOTH DISORDER 13 0.0006
209 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
210 DROOLING 4 0.0006
211 PERIORBITAL OEDEMA 3 0.0006
212 TENDERNESS 6 0.0006
213 BLOOD CALCIUM INCREASED 5 0.0006
214 FOOD CRAVING 3 0.0006
215 SPINAL OSTEOARTHRITIS 5 0.0006
216 FACIAL PARESIS 2 0.0006
217 PAIN IN JAW 16 0.0006
218 JOINT INJURY 12 0.0006
219 APPENDICECTOMY 2 0.0006
220 GALLBLADDER DISORDER 10 0.0006
221 GASTROINTESTINAL INFECTION 5 0.0006
222 THERAPEUTIC RESPONSE UNEXPECTED 25 0.0006
223 PRODUCT RESIDUE PRESENT 3 0.0006
224 BRUXISM 3 0.0006
225 DECREASED ACTIVITY 6 0.0006
226 SINUS DISORDER 11 0.0006
227 CHEILITIS 3 0.0006
228 TIC 3 0.0005
229 JAW DISORDER 3 0.0005
230 MAJOR DEPRESSION 4 0.0005
231 DEAFNESS UNILATERAL 3 0.0005
232 INFUSION SITE PAIN 7 0.0005
233 NERVE COMPRESSION 5 0.0005
234 SUNBURN 4 0.0005
235 ORAL PAIN 12 0.0005
236 FIBROMYALGIA 13 0.0005
237 DERMATITIS CONTACT 6 0.0005
238 FEELING JITTERY 10 0.0005
239 EYE INFLAMMATION 5 0.0005
240 HYPERSOMNIA 15 0.0005
241 DRY EYE 26 0.0005
242 DEVICE RELATED INFECTION 8 0.0005
243 SINUS CONGESTION 7 0.0005
244 ERUCTATION 10 0.0005
245 ANKLE FRACTURE 8 0.0005
246 PERIPHERAL COLDNESS 7 0.0005
247 PRODUCT USE COMPLAINT 8 0.0005
248 BLOOD IRON DECREASED 6 0.0005
249 HEAD INJURY 16 0.0005
250 SINUS HEADACHE 3 0.0005
251 RENAL CYST 4 0.0005
252 POLLAKIURIA 21 0.0005
253 COORDINATION ABNORMAL 7 0.0005
254 CEREBRAL ATROPHY 2 0.0005
255 NECK PAIN 28 0.0005
256 CANDIDIASIS 2 0.0005
257 ENURESIS 2 0.0005
258 NOCTURIA 6 0.0005
259 BONE DISORDER 9 0.0005
260 MUSCLE TIGHTNESS 8 0.0005
261 APPLICATION SITE DISCOLOURATION 2 0.0005
262 BACK DISORDER 8 0.0005
263 SPINAL OPERATION 6 0.0005
264 GAIT DISTURBANCE 93 0.0005
265 PIGMENTATION DISORDER 3 0.0005
266 GENERALISED OEDEMA 6 0.0005
267 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
268 WEIGHT FLUCTUATION 5 0.0005
269 SENSATION OF FOREIGN BODY 4 0.0005
270 BALANCE DISORDER 41 0.0005
271 MUSCULOSKELETAL DISORDER 9 0.0005
272 ALCOHOLISM 2 0.0005
273 BLOOD POTASSIUM DECREASED 14 0.0005
274 POOR QUALITY SLEEP 10 0.0005
275 APHASIA 14 0.0005
276 DYSPHAGIA 44 0.0005
277 INCOHERENT 3 0.0005
278 PSYCHOLOGICAL TRAUMA 4 0.0005
279 BLOOD COUNT ABNORMAL 7 0.0005
280 DYSPHONIA 27 0.0005
281 HERPES SIMPLEX 3 0.0005
282 HAEMORRHOIDS 9 0.0005
283 RESPIRATORY TRACT INFECTION 12 0.0005
284 GASTROOESOPHAGEAL REFLUX DISEASE 37 0.0005
285 KIDNEY INFECTION 9 0.0005
286 POLYP 3 0.0005
287 MUSCULOSKELETAL PAIN 24 0.0005
288 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
289 DIVERTICULUM INTESTINAL 2 0.0005
290 EYE SWELLING 17 0.0005
291 ASPIRATION 5 0.0005
292 BEDRIDDEN 6 0.0005
293 GROIN PAIN 4 0.0005
294 DYSGRAPHIA 3 0.0005
295 TOOTH INFECTION 6 0.0005
296 RED BLOOD CELL COUNT DECREASED 13 0.0005
297 PRODUCT FORMULATION ISSUE 3 0.0005
298 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
299 LUNG INFILTRATION 4 0.0005
300 DYSMENORRHOEA 6 0.0005
301 NEUROPATHY PERIPHERAL 43 0.0005
302 CHOLECYSTITIS CHRONIC 3 0.0004
303 BRAIN FOG 7 0.0004
304 RASH PAPULAR 10 0.0004
305 OCULAR DISCOMFORT 5 0.0004
306 ABASIA 11 0.0004
307 ANGER 15 0.0004
308 PRODUCT TASTE ABNORMAL 6 0.0004
309 EYE INFECTION 5 0.0004
310 DRUG EFFECT DELAYED 2 0.0004
311 LIP DRY 4 0.0004
312 PELVIC PAIN 8 0.0004
313 PANIC ATTACK 16 0.0004
314 SCAB 5 0.0004
315 SWELLING 41 0.0004
316 NIGHT SWEATS 14 0.0004
317 LYMPHOEDEMA 3 0.0004
318 LARGE INTESTINE POLYP 3 0.0004
319 ARTHRITIS 34 0.0004
320 FORMICATION 3 0.0004
321 FEELING COLD 12 0.0004
322 MASS 6 0.0004
323 FEELING OF DESPAIR 2 0.0004
324 RIGHT VENTRICULAR FAILURE 3 0.0004
325 BLOOD TEST ABNORMAL 6 0.0004
326 FLANK PAIN 4 0.0004
327 INSOMNIA 113 0.0004
328 PHOTOSENSITIVITY REACTION 7 0.0004
329 THROAT IRRITATION 19 0.0004
330 HAND FRACTURE 3 0.0004
331 THERMAL BURN 3 0.0004
332 INTENTIONAL PRODUCT USE ISSUE 37 0.0004
333 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
334 INFLUENZA 47 0.0004
335 BLOOD URINE PRESENT 8 0.0004
336 NERVOUSNESS 22 0.0004
337 CARDIAC TAMPONADE 2 0.0004
338 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
339 FEELING ABNORMAL 100 0.0004
340 WRIST FRACTURE 5 0.0004
341 PRODUCT SUBSTITUTION ISSUE 24 0.0004
342 FAECAL INCONTINENCE 2 0.0004
343 APHAGIA 2 0.0004
344 GLAUCOMA 8 0.0004
345 TONGUE DISORDER 3 0.0004
346 CANDIDA INFECTION 7 0.0004
347 ANOSMIA 6 0.0004
348 FINGER DEFORMITY 2 0.0004
349 DIZZINESS POSTURAL 4 0.0004
350 RASH PUSTULAR 3 0.0004
351 AUTOIMMUNE DISORDER 4 0.0004
352 CHOKING 8 0.0004
353 ORAL DISORDER 3 0.0004
354 MOUTH HAEMORRHAGE 3 0.0004
355 DYSURIA 15 0.0004
356 MUSCLE SPASTICITY 5 0.0004
357 VITREOUS FLOATERS 4 0.0004
358 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
359 THERAPY CHANGE 4 0.0004
360 DRY MOUTH 33 0.0004
361 MUSCULOSKELETAL DISCOMFORT 7 0.0004
362 BODY TEMPERATURE DECREASED 4 0.0004
363 APPLICATION SITE BURN 2 0.0004
364 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
365 FLATULENCE 23 0.0004
366 URINARY INCONTINENCE 12 0.0004
367 MOVEMENT DISORDER 13 0.0004
368 SKIN HAEMORRHAGE 6 0.0004
369 DISABILITY 8 0.0004
370 LIGAMENT SPRAIN 4 0.0004
371 DIABETIC NEUROPATHY 2 0.0004
372 FEELING DRUNK 3 0.0004
373 CATARACT 24 0.0004
374 BLOOD PRESSURE ABNORMAL 8 0.0004
375 HAIR COLOUR CHANGES 5 0.0004
376 LOCAL SWELLING 7 0.0004
377 GENERAL SYMPTOM 3 0.0004
378 HOT FLUSH 30 0.0004
379 TENDON PAIN 3 0.0004
380 ECONOMIC PROBLEM 6 0.0004
381 DYSPHORIA 2 0.0004
382 MUSCLE ATROPHY 5 0.0004
383 MYALGIA 67 0.0004
384 DYSLIPIDAEMIA 2 0.0004
385 MUSCLE TWITCHING 9 0.0004
386 EAR DISCOMFORT 4 0.0004
387 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
388 DISTURBANCE IN ATTENTION 21 0.0004
389 ROTATOR CUFF SYNDROME 5 0.0004
390 OSTEOPOROSIS 16 0.0004
391 FOOD ALLERGY 3 0.0004
392 LIMB DISCOMFORT 12 0.0004
393 TEMPERATURE INTOLERANCE 4 0.0004
394 CONCUSSION 3 0.0004
395 HIATUS HERNIA 5 0.0004
396 DIPLOPIA 10 0.0004
397 RESTLESS LEGS SYNDROME 7 0.0004
398 CONTUSION 37 0.0004
399 BACK PAIN 89 0.0004
400 TRANSFUSION 4 0.0004
401 AFFECTIVE DISORDER 3 0.0004
402 SINUSITIS 39 0.0004
403 JOINT DISLOCATION 4 0.0004
404 MUSCULAR WEAKNESS 43 0.0004
405 BRONCHITIS 28 0.0004
406 BLOOD ALBUMIN DECREASED 3 0.0004
407 TRICUSPID VALVE INCOMPETENCE 3 0.0004
408 VERTIGO 23 0.0004
409 RENAL PAIN 4 0.0004
410 SCIATICA 6 0.0004
411 EAR INFECTION 10 0.0004
412 BLOOD PRESSURE FLUCTUATION 9 0.0004
413 BLOOD GLUCOSE DECREASED 18 0.0004
414 SENSORY DISTURBANCE 6 0.0004
415 COMPRESSION FRACTURE 2 0.0004
416 IRRITABLE BOWEL SYNDROME 8 0.0004
417 EYE PAIN 21 0.0004
418 BLOOD POTASSIUM INCREASED 6 0.0004
419 DECUBITUS ULCER 3 0.0004
420 BACK INJURY 4 0.0004
421 PULMONARY THROMBOSIS 4 0.0004
422 MOOD ALTERED 10 0.0004
423 GINGIVAL BLEEDING 5 0.0004
424 ABNORMAL FAECES 3 0.0004
425 HICCUPS 3 0.0004
426 HERPES ZOSTER 21 0.0004
427 LETHARGY 21 0.0004
428 EYE DISORDER 12 0.0004
429 DEPRESSION 83 0.0004
430 DRUG PRESCRIBING ERROR 7 0.0004
431 LOWER LIMB FRACTURE 7 0.0004
432 HAIR DISORDER 3 0.0004
433 INJECTION SITE NODULE 4 0.0004
434 SPINAL COMPRESSION FRACTURE 3 0.0004
435 TOOTH FRACTURE 4 0.0004
436 MUSCLE INJURY 3 0.0004
437 WEIGHT INCREASED 81 0.0004
438 PROCEDURAL PAIN 10 0.0004
439 FEELING HOT 22 0.0004
440 PALPITATIONS 42 0.0004
441 CONSTIPATION 78 0.0004
442 INCORRECT DRUG ADMINISTRATION DURATION 10 0.0004
443 FLUSHING 36 0.0004
444 APPLICATION SITE PRURITUS 8 0.0004
445 HYPOPHAGIA 9 0.0004
446 SCAR 6 0.0004
447 PSEUDOMONAS INFECTION 3 0.0003
448 PAIN IN EXTREMITY 103 0.0003
449 SPINAL FRACTURE 7 0.0003
450 PARALYSIS 5 0.0003
451 MUSCLE STRAIN 3 0.0003
452 HYPERTHYROIDISM 5 0.0003
453 URINE OUTPUT DECREASED 3 0.0003
454 APATHY 5 0.0003
455 COGNITIVE DISORDER 16 0.0003
456 DYSSTASIA 10 0.0003
457 SPLENOMEGALY 4 0.0003
458 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
459 SURGERY 20 0.0003
460 GRIP STRENGTH DECREASED 3 0.0003
461 WEIGHT DECREASED 95 0.0003
462 FATIGUE 264 0.0003
463 LYMPHADENOPATHY 12 0.0003
464 COVID-19 PNEUMONIA 4 0.0003
465 ANXIETY 96 0.0003
466 FACIAL PAIN 3 0.0003
467 PULMONARY MASS 5 0.0003
468 ABDOMINAL DISTENSION 35 0.0003
469 COUGH 94 0.0003
470 PREGNANCY WITH CONTRACEPTIVE DEVICE 3 0.0003
471 HYPERLIPIDAEMIA 4 0.0003
472 ABDOMINAL DISCOMFORT 56 0.0003
473 HEADACHE 209 0.0003
474 KNEE ARTHROPLASTY 7 0.0003
475 OSTEOMYELITIS 6 0.0003
476 BLOOD PRESSURE DECREASED 22 0.0003
477 CRYING 12 0.0003
478 EYE IRRITATION 19 0.0003
479 BURSITIS 4 0.0003
480 ADRENAL INSUFFICIENCY 4 0.0003
481 EATING DISORDER 7 0.0003
482 HYPOAESTHESIA 49 0.0003
483 BRAIN NEOPLASM 3 0.0003
484 TINNITUS 15 0.0003
485 SKIN DISCOLOURATION 15 0.0003
486 INCREASED TENDENCY TO BRUISE 3 0.0003
487 ABNORMAL DREAMS 9 0.0003
488 RHEUMATOID ARTHRITIS 37 0.0003
489 SLEEP DISORDER 23 0.0003
490 DYSPEPSIA 32 0.0003
491 OROPHARYNGEAL PAIN 30 0.0003
492 TENDON RUPTURE 4 0.0003
493 HYPERCALCAEMIA 4 0.0003
494 PRURITUS GENERALISED 7 0.0003
495 MUSCULOSKELETAL CHEST PAIN 5 0.0003
496 TENDONITIS 5 0.0003
497 HAEMOPTYSIS 9 0.0003
498 THINKING ABNORMAL 6 0.0003
499 APPLICATION SITE IRRITATION 4 0.0003
500 DEFORMITY 3 0.0003
501 AGEUSIA 8 0.0003
502 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
503 ARTERIOSCLEROSIS 3 0.0003
504 BLEPHAROSPASM 2 0.0003
505 PAIN 194 0.0003
506 DRUG EFFECT DECREASED 17 0.0003
507 DISEASE RECURRENCE 15 0.0003
508 MIGRAINE 30 0.0003
509 BLOOD PRESSURE INCREASED 48 0.0003
510 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
511 INTRAOCULAR PRESSURE INCREASED 4 0.0003
512 PULMONARY FIBROSIS 6 0.0003
513 SNEEZING 7 0.0003
514 ROAD TRAFFIC ACCIDENT 13 0.0003
515 URINARY TRACT INFECTION 53 0.0003
516 ATELECTASIS 3 0.0003
517 PRESCRIBED OVERDOSE 6 0.0003
518 INJECTION SITE INDURATION 4 0.0003
519 APPLICATION SITE VESICLES 2 0.0003
520 ANAPHYLACTIC REACTION 17 0.0003
521 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
522 VITAMIN D DEFICIENCY 3 0.0003
523 SWELLING FACE 20 0.0003
524 PLATELET COUNT INCREASED 4 0.0003
525 MENORRHAGIA 6 0.0003
526 APPLICATION SITE ERYTHEMA 8 0.0003
527 GASTRITIS 8 0.0003
528 INFECTION 44 0.0003
529 ORAL CANDIDIASIS 4 0.0003
530 WHEEZING 18 0.0003
531 IMMUNE SYSTEM DISORDER 4 0.0003
532 PULMONARY CONGESTION 4 0.0003
533 HAEMATOCRIT DECREASED 6 0.0003
534 INABILITY TO AFFORD MEDICATION 3 0.0003
535 EXPIRED PRODUCT ADMINISTERED 10 0.0003
536 ASTHENIA 113 0.0003
537 DRUG INTOLERANCE 29 0.0003
538 MUSCLE SPASMS 55 0.0003
539 HAIR TEXTURE ABNORMAL 4 0.0003
540 DIZZINESS 149 0.0003
541 CHILLS 35 0.0003
542 ARTHRALGIA 124 0.0003
543 PRODUCT USE ISSUE 56 0.0003
544 LACRIMATION INCREASED 9 0.0003
545 THROAT TIGHTNESS 8 0.0003
546 TASTE DISORDER 6 0.0003
547 FLUID RETENTION 15 0.0003
548 SUBARACHNOID HAEMORRHAGE 3 0.0003
549 LIMB INJURY 8 0.0003
550 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5 0.0003
551 MOTOR DYSFUNCTION 3 0.0003
552 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
553 SLUGGISHNESS 3 0.0003
554 IMPAIRED GASTRIC EMPTYING 4 0.0003
555 PRODUCTIVE COUGH 14 0.0003
556 DYSARTHRIA 11 0.0003
557 EYE MOVEMENT DISORDER 2 0.0003
558 DYSPNOEA EXERTIONAL 11 0.0003
559 PRODUCT PREPARATION ERROR 6 0.0003
560 ASTHMA 33 0.0003
561 ECCHYMOSIS 2 0.0003
562 FALL 97 0.0003
563 GASTRIC DISORDER 10 0.0003
564 VISION BLURRED 40 0.0003
565 PRODUCT DOSE OMISSION 19 0.0003
566 PARANOIA 5 0.0003
567 NASAL CONGESTION 17 0.0003
568 PRESYNCOPE 7 0.0003
569 NEURALGIA 7 0.0003
570 ORAL DISCOMFORT 4 0.0003
571 ATRIAL FIBRILLATION 28 0.0003
572 PETECHIAE 3 0.0003
573 ORTHOSTATIC HYPOTENSION 5 0.0003
574 APHONIA 4 0.0003
575 ABDOMINAL PAIN UPPER 59 0.0003
576 DEMENTIA 8 0.0003
577 DEHYDRATION 38 0.0003
578 HEART RATE DECREASED 10 0.0003
579 INJURY 20 0.0003
580 DUODENAL ULCER 2 0.0003
581 CHEST DISCOMFORT 29 0.0003
582 DYSGEUSIA 21 0.0003
583 SINUS TACHYCARDIA 4 0.0003
584 ALOPECIA 55 0.0003
585 HYPERTENSION 59 0.0003
586 CELLULITIS 14 0.0003
587 UNEVALUABLE EVENT 21 0.0003
588 PARAESTHESIA ORAL 4 0.0003
589 ABDOMINAL PAIN LOWER 7 0.0003
590 FAECES DISCOLOURED 6 0.0003
591 AMNESIA 18 0.0003
592 MEMORY IMPAIRMENT 38 0.0003
593 OEDEMA 15 0.0003
594 DIARRHOEA 178 0.0003
595 INJECTION SITE HAEMATOMA 4 0.0003
596 PRODUCT PRESCRIBING ISSUE 6 0.0003
597 UNDERDOSE 20 0.0003
598 GASTROINTESTINAL PAIN 3 0.0003
599 RASH ERYTHEMATOUS 13 0.0003
600 INFLAMMATION 14 0.0003
601 BLINDNESS TRANSIENT 2 0.0003
602 TREMOR 45 0.0003
603 LABORATORY TEST ABNORMAL 8 0.0003
604 BURNING SENSATION 19 0.0003
605 SKIN ULCER 7 0.0003
606 FOOT DEFORMITY 3 0.0003
607 FUNGAL INFECTION 9 0.0003
608 ARTHROPOD BITE 2 0.0003
609 CONJUNCTIVITIS 5 0.0003
610 IMMUNODEFICIENCY 4 0.0003
611 MIDDLE INSOMNIA 5 0.0003
612 DYSPNOEA 151 0.0003
613 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
614 ANHEDONIA 7 0.0003
615 PERIPHERAL SWELLING 41 0.0003
616 NASOPHARYNGITIS 49 0.0003
617 BREAST TENDERNESS 2 0.0003
618 HALLUCINATION 20 0.0003
619 MITRAL VALVE INCOMPETENCE 3 0.0003
620 MALAISE 116 0.0003
621 FOOT FRACTURE 5 0.0003
622 PRODUCT AVAILABILITY ISSUE 6 0.0003
623 RHINORRHOEA 17 0.0003
624 AORTIC ANEURYSM 2 0.0003
625 DEVICE FAILURE 4 0.0003
626 DECREASED APPETITE 61 0.0003
627 CHOLECYSTECTOMY 3 0.0003
628 DRUG DISPENSING ERROR 4 0.0003
629 INCREASED APPETITE 5 0.0003
630 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
631 FEAR 7 0.0003
632 PHARYNGEAL OEDEMA 4 0.0003
633 RASH PRURITIC 14 0.0003
634 ELECTROLYTE IMBALANCE 3 0.0003
635 APHTHOUS ULCER 2 0.0003
636 JOINT SWELLING 31 0.0003
637 HYPERHIDROSIS 33 0.0003
638 ORAL HERPES 5 0.0003
639 SWOLLEN TONGUE 8 0.0003
640 EPISTAXIS 19 0.0003
641 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
642 MENTAL DISORDER 11 0.0003
643 HEART RATE INCREASED 25 0.0003
644 PRODUCT ADHESION ISSUE 9 0.0003
645 ULCER 4 0.0003
646 CYSTITIS 8 0.0003
647 MACULAR DEGENERATION 3 0.0003
648 UPPER LIMB FRACTURE 5 0.0003
649 COVID-19 44 0.0003
650 HEPATITIS C 3 0.0002
651 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
652 MENTAL IMPAIRMENT 6 0.0002
653 NAUSEA 195 0.0002
654 DYSKINESIA 10 0.0002
655 NO THERAPEUTIC RESPONSE 3 0.0002
656 CARDIOMEGALY 3 0.0002
657 SMALL INTESTINAL OBSTRUCTION 3 0.0002
658 IMPAIRED HEALING 8 0.0002
659 INJECTION SITE MASS 9 0.0002
660 SOMNOLENCE 49 0.0002
661 INJECTION SITE WARMTH 5 0.0002
662 STAPHYLOCOCCAL INFECTION 8 0.0002
663 PULMONARY EMBOLISM 23 0.0002
664 CYST 3 0.0002
665 TOOTH EXTRACTION 3 0.0002
666 EMBOLISM 2 0.0002
667 VIRAL INFECTION 8 0.0002
668 SUICIDAL IDEATION 22 0.0002
669 LIP SWELLING 8 0.0002
670 INJECTION SITE DISCOLOURATION 3 0.0002
671 EOSINOPHIL COUNT INCREASED 2 0.0002
672 MUSCULOSKELETAL STIFFNESS 21 0.0002
673 BLOOD UREA INCREASED 4 0.0002
674 RASH 104 0.0002
675 DERMATITIS ALLERGIC 3 0.0002
676 OEDEMA PERIPHERAL 29 0.0002
677 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
678 MOBILITY DECREASED 17 0.0002
679 FACIAL PARALYSIS 2 0.0002
680 METRORRHAGIA 4 0.0002
681 GASTROINTESTINAL DISORDER 21 0.0002
682 VISUAL IMPAIRMENT 29 0.0002
683 IMPAIRED WORK ABILITY 5 0.0002
684 HAEMOGLOBIN DECREASED 24 0.0002
685 ILLNESS 24 0.0002
686 URTICARIA 39 0.0002
687 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
688 SKIN CANCER 5 0.0002
689 BLOOD MAGNESIUM DECREASED 2 0.0002
690 BLISTER 13 0.0002
691 AGITATION 17 0.0002
692 INFLUENZA LIKE ILLNESS 19 0.0002
693 VAGINAL HAEMORRHAGE 10 0.0002
694 DEAFNESS 6 0.0002
695 INCORRECT PRODUCT STORAGE 3 0.0002
696 APPLICATION SITE PAIN 5 0.0002
697 ADVERSE REACTION 3 0.0002
698 FEMUR FRACTURE 7 0.0002
699 DRUG ERUPTION 4 0.0002
700 EYE HAEMORRHAGE 3 0.0002
701 THIRST 4 0.0002
702 JOINT RANGE OF MOTION DECREASED 3 0.0002
703 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
704 GOUT 4 0.0002
705 PAIN OF SKIN 6 0.0002
706 PARAESTHESIA 35 0.0002
707 PNEUMONIA 72 0.0002
708 DEVICE BREAKAGE 9 0.0002
709 CHEST PAIN 41 0.0002
710 TOOTHACHE 4 0.0002
711 MOOD SWINGS 7 0.0002
712 CORONARY ARTERY OCCLUSION 3 0.0002
713 SKIN LESION 6 0.0002
714 SKIN IRRITATION 10 0.0002
715 BLOOD GLUCOSE ABNORMAL 4 0.0002
716 DIVERTICULITIS 6 0.0002
717 HEPATIC STEATOSIS 4 0.0002
718 WOUND 6 0.0002
719 PRODUCT QUALITY ISSUE 29 0.0002
720 BLINDNESS UNILATERAL 3 0.0002
721 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
722 LOSS OF CONSCIOUSNESS 27 0.0002
723 OCULAR HYPERAEMIA 10 0.0002
724 URINARY RETENTION 7 0.0002
725 GAIT INABILITY 7 0.0002
726 SKIN BURNING SENSATION 15 0.0002
727 MULTIPLE SCLEROSIS 10 0.0002
728 HYPOACUSIS 9 0.0002
729 EYE PRURITUS 7 0.0002
730 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
731 ABDOMINAL PAIN 48 0.0002
732 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
733 OSTEONECROSIS OF JAW 5 0.0002
734 DISORIENTATION 8 0.0002
735 DRUG INEFFECTIVE 266 0.0002
736 HOSPITALISATION 31 0.0002
737 COLITIS ULCERATIVE 9 0.0002
738 TREATMENT NONCOMPLIANCE 11 0.0002
739 HAEMORRHAGE INTRACRANIAL 3 0.0002
740 RESPIRATORY DISORDER 6 0.0002
741 IRRITABILITY 12 0.0002
742 PRODUCT PHYSICAL ISSUE 4 0.0002
743 STOMATITIS 12 0.0002
744 VOMITING 93 0.0002
745 EXTRA DOSE ADMINISTERED 8 0.0002
746 PLATELET COUNT DECREASED 21 0.0002
747 DISCOMFORT 12 0.0002
748 DRUG LEVEL DECREASED 2 0.0002
749 NEPHROLITHIASIS 9 0.0002
750 HIP ARTHROPLASTY 3 0.0002
751 ADVERSE EVENT 18 0.0002
752 DRY SKIN 26 0.0002
753 RIB FRACTURE 4 0.0002
754 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
755 INTENTIONAL PRODUCT MISUSE 17 0.0002
756 LYMPHOMA 3 0.0002
757 RENAL DISORDER 9 0.0002
758 HAEMATOMA 5 0.0002
759 PRURITUS 74 0.0002
760 EYE DISCHARGE 2 0.0002
761 CARDIAC DISORDER 18 0.0002
762 BASAL CELL CARCINOMA 3 0.0002
763 INTENTIONAL DRUG MISUSE 4 0.0002
764 BLOOD GLUCOSE INCREASED 36 0.0002
765 SEDATION 5 0.0002
766 ARRHYTHMIA 9 0.0002
767 MOUTH ULCERATION 4 0.0002
768 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
769 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
770 PANCREATITIS 10 0.0002
771 RESPIRATORY TRACT CONGESTION 3 0.0002
772 HALLUCINATION, AUDITORY 3 0.0002
773 ABSCESS 3 0.0002
774 BREAST CANCER FEMALE 5 0.0002
775 HIP FRACTURE 6 0.0002
776 INTESTINAL OBSTRUCTION 7 0.0002
777 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
778 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
779 HYPOTENSION 37 0.0002
780 DEVICE DISLOCATION 8 0.0002
781 BIPOLAR DISORDER 2 0.0002
782 LUNG DISORDER 9 0.0002
783 ANAEMIA 35 0.0002
784 CHOLELITHIASIS 6 0.0002
785 METASTASES TO BONE 3 0.0002
786 MULTIPLE FRACTURES 3 0.0002
787 DRUG WITHDRAWAL SYNDROME 16 0.0002
788 VENTRICULAR TACHYCARDIA 3 0.0002
789 DRUG DOSE OMISSION 30 0.0002
790 THERAPEUTIC RESPONSE DECREASED 11 0.0002
791 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
792 PLEURAL EFFUSION 11 0.0002
793 TACHYCARDIA 16 0.0002
794 ARTHROPATHY 10 0.0002
795 PERICARDITIS 3 0.0002
796 TYPE 2 DIABETES MELLITUS 6 0.0002
797 ADVERSE DRUG REACTION 16 0.0002
798 THERAPY NON-RESPONDER 8 0.0002
799 BLOOD CALCIUM DECREASED 2 0.0002
800 HYPERSENSITIVITY 33 0.0002
801 ABNORMAL BEHAVIOUR 7 0.0002
802 PYREXIA 61 0.0002
803 CIRCULATORY COLLAPSE 3 0.0002
804 HEPATIC ENZYME INCREASED 12 0.0002
805 INJECTION SITE BRUISING 14 0.0002
806 SEIZURE 20 0.0002
807 DEVICE DEFECTIVE 3 0.0002
808 PERICARDIAL EFFUSION 4 0.0002
809 PSORIATIC ARTHROPATHY 7 0.0002
810 HAEMORRHAGE 18 0.0002
811 EYELID OEDEMA 2 0.0002
812 RASH MACULAR 6 0.0002
813 AMENORRHOEA 3 0.0002
814 INCORRECT DOSE ADMINISTERED 39 0.0002
815 DIABETES MELLITUS 13 0.0002
816 DEPRESSED MOOD 9 0.0002
817 PSYCHOTIC DISORDER 5 0.0002
818 DEEP VEIN THROMBOSIS 11 0.0002
819 ATAXIA 2 0.0002
820 PRODUCT PRESCRIBING ERROR 4 0.0002
821 ACCIDENT 2 0.0002
822 CONFUSIONAL STATE 27 0.0002
823 SKIN EXFOLIATION 14 0.0002
824 CEREBROVASCULAR ACCIDENT 28 0.0002
825 HYPOGLYCAEMIA 8 0.0002
826 CONDITION AGGRAVATED 50 0.0002
827 INJECTION SITE PRURITUS 11 0.0002
828 PRODUCT DOSE OMISSION ISSUE 48 0.0002
829 RECTAL HAEMORRHAGE 7 0.0002
830 DRUG ADMINISTRATION ERROR 5 0.0002
831 THROMBOSIS 13 0.0002
832 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
833 BACTERIAL INFECTION 3 0.0002
834 SYNCOPE 16 0.0002
835 INJECTION SITE PAIN 49 0.0002
836 HEPATIC CIRRHOSIS 3 0.0002
837 PRODUCT COMPLAINT 4 0.0002
838 PROTEINURIA 3 0.0002
839 POST PROCEDURAL COMPLICATION 3 0.0002
840 DEVICE ISSUE 14 0.0002
841 THERAPY CESSATION 8 0.0002
842 RASH GENERALISED 4 0.0002
843 EXPOSURE VIA SKIN CONTACT 4 0.0002
844 EAR PAIN 3 0.0002
845 SKIN FISSURES 3 0.0002
846 INJECTION SITE ERYTHEMA 19 0.0002
847 SPEECH DISORDER 8 0.0002
848 HYPOKALAEMIA 7 0.0002
849 BRADYCARDIA 8 0.0002
850 COMPLICATION OF DEVICE INSERTION 3 0.0002
851 VISUAL ACUITY REDUCED 5 0.0002
852 OFF LABEL USE 131 0.0001
853 FREQUENT BOWEL MOVEMENTS 4 0.0001
854 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 30 0.0001
855 BODY TEMPERATURE INCREASED 3 0.0001
856 PALLOR 4 0.0001
857 HAEMATURIA 5 0.0001
858 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
859 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
860 NIGHTMARE 5 0.0001
861 MENTAL STATUS CHANGES 4 0.0001
862 PULMONARY HYPERTENSION 3 0.0001
863 MEDICATION ERROR 8 0.0001
864 DEVICE MALFUNCTION 10 0.0001
865 DEVICE OCCLUSION 2 0.0001
866 ERYTHEMA 29 0.0001
867 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
868 PANCREATIC CARCINOMA 4 0.0001
869 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
870 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
871 BLOOD CREATININE INCREASED 9 0.0001
872 PRODUCT DISPENSING ERROR 3 0.0001
873 MYOCARDIAL INFARCTION 24 0.0001
874 C-REACTIVE PROTEIN INCREASED 5 0.0001
875 ACCIDENTAL OVERDOSE 5 0.0001
876 RESTLESSNESS 5 0.0001
877 CARDIOMYOPATHY 2 0.0001
878 SEPSIS 15 0.0001
879 PULMONARY OEDEMA 6 0.0001
880 CHROMATURIA 3 0.0001
881 DERMATITIS ATOPIC 7 0.0001
882 CORONARY ARTERY DISEASE 4 0.0001
883 COLITIS 5 0.0001
884 ACNE 10 0.0001
885 EMOTIONAL DISORDER 4 0.0001
886 BREAST CANCER 12 0.0001
887 DELUSION 2 0.0001
888 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
889 NERVOUS SYSTEM DISORDER 4 0.0001
890 PLASMA CELL MYELOMA 5 0.0001
891 BONE DENSITY DECREASED 4 0.0001
892 CYANOSIS 2 0.0001
893 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
894 PANCYTOPENIA 7 0.0001
895 LOCALISED INFECTION 3 0.0001
896 INTERSTITIAL LUNG DISEASE 6 0.0001
897 EMOTIONAL DISTRESS 15 0.0001
898 COAGULOPATHY 2 0.0001
899 CARDIOVASCULAR DISORDER 3 0.0001
900 INJECTION SITE SWELLING 9 0.0001
901 HEPATITIS 3 0.0001
902 INJECTION SITE REACTION 8 0.0001
903 DELIRIUM 4 0.0001
904 ECZEMA 6 0.0001
905 JOINT STIFFNESS 3 0.0001
906 LIVER DISORDER 5 0.0001
907 EXPOSURE DURING PREGNANCY 7 0.0001
908 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
909 CARDIAC FAILURE 9 0.0001
910 CARDIAC FAILURE CONGESTIVE 9 0.0001
911 BLOOD BILIRUBIN INCREASED 3 0.0001
912 COMPLICATION OF DEVICE REMOVAL 2 0.0001
913 END STAGE RENAL DISEASE 2 0.0001
914 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
915 COMPLETED SUICIDE 9 0.0001
916 DEVICE EXPULSION 7 0.0001
917 OXYGEN SATURATION DECREASED 6 0.0001
918 TARDIVE DYSKINESIA 3 0.0001
919 BLOOD SODIUM DECREASED 2 0.0001
920 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
921 INTENTIONAL DOSE OMISSION 3 0.0001
922 ANGINA PECTORIS 3 0.0001
923 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
924 LIVER FUNCTION TEST ABNORMAL 3 0.0001
925 INJECTION SITE HAEMORRHAGE 8 0.0001
926 CYTOKINE RELEASE SYNDROME 2 0.0001
927 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
928 ILL-DEFINED DISORDER 6 0.0001
929 FEEDING DISORDER 2 0.0001
930 BONE MARROW FAILURE 2 0.0001
931 NEUTROPHIL COUNT DECREASED 4 0.0001
932 CARDIO-RESPIRATORY ARREST 4 0.0001
933 DERMATITIS 2 0.0001
934 DRUG INTERACTION 15 0.0001
935 CHRONIC KIDNEY DISEASE 7 0.0001
936 PSORIASIS 12 0.0001
937 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
938 SKIN DISORDER 3 0.0001
939 DRUG DOSE OMISSION BY DEVICE 7 0.0001
940 NO ADVERSE EVENT 16 0.0001
941 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
942 DEVICE USE ERROR 3 0.0001
943 CARDIAC ARREST 7 0.0001
944 COMA 4 0.0001
945 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
946 RENAL IMPAIRMENT 7 0.0001
947 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
948 DIABETIC KETOACIDOSIS 2 0.0001
949 RENAL FAILURE 11 0.0001
950 DRUG EFFECT INCOMPLETE 3 0.0001
951 ENCEPHALOPATHY 2 0.0001
952 LEUKOPENIA 4 0.0001
953 PRODUCT STORAGE ERROR 7 0.0001
954 ACUTE KIDNEY INJURY 12 0.0001
955 ERECTILE DYSFUNCTION 2 0.0001
956 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
957 INFUSION RELATED REACTION 5 0.0001
958 FEBRILE NEUTROPENIA 5 0.0001
959 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
960 OVERDOSE 16 0.0001
961 HAEMATOCHEZIA 4 0.0001
962 THROMBOCYTOPENIA 8 0.0001
963 HYPONATRAEMIA 4 0.0001
964 RENAL FAILURE ACUTE 3 0.0001
965 THERAPY INTERRUPTED 5 0.0001
966 DEVICE LEAKAGE 3 0.0001
967 SEPTIC SHOCK 3 0.0001
968 DRUG DEPENDENCE 11 0.0001
969 SUICIDE ATTEMPT 4 0.0001
970 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
971 DRUG-INDUCED LIVER INJURY 2 0.0001
972 AGGRESSION 3 0.0001
973 NEOPLASM MALIGNANT 4 0.0001
974 NEUTROPENIA 8 0.0001
975 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
976 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
977 CEREBRAL HAEMORRHAGE 2 0.0001
978 DEATH 47 0.0001
979 TOXICITY TO VARIOUS AGENTS 9 0.0001
980 CONVULSION 3 0.0001
981 DISEASE PROGRESSION 6 0.0001
982 ABORTION SPONTANEOUS 2 0.0000
983 BLINDNESS 2 0.0000
984 INTENTIONAL OVERDOSE 3 0.0000
985 DEVICE DIFFICULT TO USE 3 0.0000
986 ANGIOEDEMA 2 0.0000
987 RESPIRATORY FAILURE 3 0.0000
988 DEPENDENCE 2 0.0000
989 DRUG ABUSE 2 0.0000